Rallybio Corp. (RLYB)
16.80
-0.03
(-0.18%)
USD |
NASDAQ |
Aug 24, 16:00
16.80
0.00 (0.00%)
After-Hours: 20:00
Rallybio Market Cap : 89.16M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 89.32M |
| August 20, 2026 | 88.09M |
| August 19, 2026 | 90.22M |
| August 18, 2026 | 89.00M |
| August 17, 2026 | 90.22M |
| August 14, 2026 | 90.16M |
| August 13, 2026 | 90.00M |
| August 12, 2026 | 88.04M |
| August 11, 2026 | 86.93M |
| August 10, 2026 | 88.15M |
| August 07, 2026 | 85.76M |
| August 06, 2026 | 85.92M |
| August 05, 2026 | 85.65M |
| August 04, 2026 | 84.70M |
| August 03, 2026 | 84.38M |
| July 31, 2026 | 84.27M |
| July 30, 2026 | 85.01M |
| July 29, 2026 | 84.43M |
| July 28, 2026 | 85.46M |
| July 27, 2026 | 86.28M |
| July 24, 2026 | 86.28M |
| July 23, 2026 | 86.71M |
| July 22, 2026 | 87.92M |
| July 21, 2026 | 89.46M |
| July 20, 2026 | 88.40M |
| Date | Value |
|---|---|
| July 17, 2026 | 86.87M |
| July 16, 2026 | 84.43M |
| July 15, 2026 | 85.33M |
| July 14, 2026 | 84.70M |
| July 13, 2026 | 84.06M |
| July 10, 2026 | 83.21M |
| July 09, 2026 | 83.74M |
| July 08, 2026 | 82.95M |
| July 07, 2026 | 82.90M |
| July 06, 2026 | 83.16M |
| July 02, 2026 | 83.66M |
| July 01, 2026 | 84.33M |
| June 30, 2026 | 84.64M |
| June 29, 2026 | 84.96M |
| June 26, 2026 | 84.64M |
| June 25, 2026 | 83.11M |
| June 24, 2026 | 84.22M |
| June 23, 2026 | 83.06M |
| June 22, 2026 | 84.27M |
| June 18, 2026 | 84.48M |
| June 17, 2026 | 84.22M |
| June 16, 2026 | 84.11M |
| June 15, 2026 | 84.11M |
| June 12, 2026 | 84.22M |
| June 11, 2026 | 84.22M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Q32 Bio, Inc. | 387.86M |
| Beam Therapeutics, Inc. | 2.927B |
| C4 Therapeutics, Inc. | 505.14M |
| Cullinan Therapeutics, Inc. | 1.410B |
| Arrowhead Pharmaceuticals, Inc. | 12.24B |
Market Cap Related Metrics
| PE Ratio | 2.151 |
| PS Ratio | 145.65 |
| Price to Book Value | 0.9435 |
| Price to Free Cash Flow | 3.522 |
| Price | 16.80 |
| Earnings Yield | 46.50% |
| Normalized PE Ratio | 6.777 |